Surrozen (SRZN)

• Market cap: $265M
• 1 day: -1.64%
• 5 days: -4.12%
• 1 month: -1.43%
• 3 months: -23.61%
• 6 months: 10.46%
• Year to date: 5.85%
• 1 year: 164.92%
• 5 years: -84.7%
• 10 years: -84.96%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Employees: 44